N-(2-(4-(trifluoromethoxy)benzyl)-2H-pyrazolo[4,3-c]pyridin-4-yl)isobutyramide | 1609091-67-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: N-(2-(4-(trifluoromethoxy)benzyl)-2H-pyrazolo[4,3-c]pyridin-4-yl)isobutyramide
• 英文别名: 2-methyl-N-[2-[[4-(trifluoromethoxy)phenyl]methyl]pyrazolo[4,3-c]pyridin-4-yl]propanamide
• CAS: 1609091-67-9
• 化学式: C₁₈H₁₇F₃N₄O₂
• 分子量: 378.354
• InChiKey: DKBYCICTMUQLOT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  69
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• [EN] PYRAZOLOPYRIDINE DERIVATIVES AS TTX-S BLOCKERS<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE EN TANT QUE BLOQUANTS DE TTX-S
  申请人：RAQUALIA PHARMA INC

  公开号：WO2014068988A1

  公开（公告）日：2014-05-08

  The present invention relates to pyrazolopyridine derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

  本发明涉及吡唑并吡啶衍生物，这些衍生物具有阻断TTX-S型电压门控钠通道的活性，并且在治疗或预防涉及电压门控钠通道的疾病和障碍中是有用的。该发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在预防或治疗涉及电压门控钠通道的疾病中的用途。
• PYRAZOLOPYRIDINE DERIVATIVES AS TTX-S BLOCKERS
  申请人：RAQUALIA PHARMA INC.

  公开号：US20150291582A1

  公开（公告）日：2015-10-15

  The present invention relates to pyrazolopyridine derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.

  本发明涉及吡唑吡啶衍生物，其具有钠离子电压门控通道的阻滞活性，包括TTX-S通道，并且可用于治疗或预防涉及钠离子电压门控通道的疾病和疾病。本发明还涉及包括这些化合物的制药组合物以及在预防或治疗涉及钠离子电压门控通道的疾病中使用这些化合物和组合物的用途。
• US9944634B2
  申请人：——

  公开号：US9944634B2

  公开（公告）日：2018-04-17